Accelerate Diagnostics Files $150M Shelf Registration | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics has filed a shelf registration to publicly offer from time to time up to $150 million of securities.

In a Form S-3 filed with the US Securities and Exchange Commission on Wednesday, the company said that it may offer common stock, preferred stock, debt securities, warrants, and/or units in combination. Net proceeds from any offering will go toward general corporate purposes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.